RegentAtlantic Capital’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,357
Closed -$240K 708
2022
Q2
$240K Buy
+1,357
New +$196K 0.01% 599
2022
Q1
Sell
-1,373
Closed -$212K 729
2021
Q4
$212K Sell
1,373
-31
-2% -$5.19K 0.01% 652
2021
Q3
$238K Sell
1,404
-819
-37% -$127K 0.01% 605
2021
Q2
$351K Buy
2,223
+567
+34% +$84.3K 0.01% 496
2021
Q1
$230K Buy
+1,656
New +$267K 0.01% 516
2020
Q4
Sell
-1,128
Closed -$221K 529
2020
Q3
$221K Buy
+1,128
New +$189K 0.01% 457

Other funds holding SGEN

RegentAtlantic Capital's SGEN Position: Q3 2022 in Review

RegentAtlantic Capital sold out of Seagen Inc. Common Stock (SGEN) in Q3 2022, closing a stake of 1,357 shares — an estimated $240K sold.

RegentAtlantic Capital first reported a position in SGEN in Q3 2020 and held it in 6 quarters. The position peaked at $351K in Q2 2021. 539 funds tracked by Wall St. Rank hold SGEN as of Q3 2022.

  • RegentAtlantic Capital reported no remaining Seagen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • RegentAtlantic Capital sold 1,357 Seagen Inc. Common Stock shares in Q3 2022, an estimated $240K.
  • RegentAtlantic Capital first reported a position in Seagen Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • RegentAtlantic Capital's Seagen Inc. Common Stock position peaked at $351K in Q2 2021.
  • 539 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.